We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
-2.24%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$522M
AUM Growth
-$19.8M
Cap. Flow
-$3.6M
Cap. Flow %
-0.69%
Top 10 Hldgs %
71.27%
Holding
80
New
1
Increased
7
Reduced
12
Closed
3

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 38.27%
2 Healthcare 35.25%
3 Energy 7.93%
4 Consumer Staples 5.82%
5 Communication Services 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$195M 37.4%
8,053,732
+58,130
+0.7% +$1.48M
BMY icon
2
Bristol-Myers Squibb
BMY
$130B
$26.1M 5%
468,325
-7,800
-2% -$424K
JNJ icon
3
Johnson & Johnson
JNJ
$626B
$25.7M 4.91%
194,000
DIS icon
4
Walt Disney
DIS
$179B
$24.9M 4.77%
234,400
-15,000
-6% -$1.64M
ZTS icon
5
Zoetis
ZTS
$31.1B
$24.5M 4.7%
393,420
ABT icon
6
Abbott
ABT
$190B
$18.1M 3.47%
372,710
PFE icon
7
Pfizer
PFE
$152B
$15.6M 2.99%
490,561
-1,687
-0.3% -$53.2K
ABBV icon
8
AbbVie
ABBV
$442B
$14.8M 2.83%
203,660
ZBH icon
9
Zimmer Biomet
ZBH
$18.5B
$13.8M 2.65%
111,086
KMB icon
10
Kimberly-Clark
KMB
$36.1B
$13.3M 2.55%
103,300
LLY icon
11
Eli Lilly
LLY
$1.08T
$12.7M 2.43%
153,915
-35
-0% -$2.85K
PM icon
12
Philip Morris
PM
$290B
$11.9M 2.27%
101,024
KMI icon
13
Kinder Morgan
KMI
$70.1B
$11.2M 2.15%
585,696
-100,000
-15% -$1.99M
MRK icon
14
Merck
MRK
$322B
$10.1M 1.93%
165,060
+159,820
+3,050% +$9.73M
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
$9.95M 1.91%
155,921
-8,280
-5% -$520K
AAPL icon
16
Apple
AAPL
$4.45T
$9.47M 1.81%
263,088
GE icon
17
GE Aerospace
GE
$382B
$8.84M 1.69%
68,274
-5,008
-7% -$686K
TCP
18
DELISTED
TC Pipelines LP
TCP
$6.94M 1.33%
126,250
BAX icon
19
Baxter International
BAX
$14.3B
$6.9M 1.32%
113,900
CAT icon
20
Caterpillar
CAT
$388B
$6.45M 1.23%
60,005
MMP
21
DELISTED
Magellan Midstream Partners, L.P.
MMP
$5.05M 0.97%
70,800
EPD icon
22
Enterprise Products Partners
EPD
$81.8B
$4.57M 0.87%
168,650
+8,000
+5% +$217K
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.14M 0.79%
24,450
-11,920
-33% -$1.98M
PG icon
24
Procter & Gamble
PG
$338B
$4.08M 0.78%
46,841
CELG
25
DELISTED
Celgene Corp
CELG
$3.22M 0.62%
24,800

Similar funds

Blackhill Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Blackhill Capital held 80 positions worth $522M, down 3.7% from $542M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Blackhill Capital's Q2 2017 filing shows 1 new, 7 increased, 12 reduced and 3 closed positions. The largest sale was Mead Johnson Nutrition Company, an estimated $6.02M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Energy.

  • Blackhill Capital added most to Merck in Q2 2017, an estimated $9.73M increase.
  • Blackhill Capital's biggest Q2 2017 reduction was Kinder Morgan, cutting an estimated $1.99M.
  • Blackhill Capital fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $6.02M.
  • Blackhill Capital's ten largest holdings make up 71% of its $522M portfolio in Q2 2017.
  • Blackhill Capital opened 1 new position and closed 3 in Q2 2017.
  • Blackhill Capital's portfolio value fell 3.7% quarter-over-quarter to $522M.

Based on Blackhill Capital's 13F filing for Q2 2017, filed 20 Jul 2017.